Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Michigan Genetic Hereditary Testing (MiGHT) [NA]
Results from the MiGHT genetic hereditary testing trial conducted at University of Michigan Rogel Cancer Center in breast, colorectal, and o…
-
CLINICAL_TRIALS trial_result · 2026-08-05Clinical Trial Results: Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating short-course radiation therapy with proton or photon beam and capecitabine with hydroxychloroquine in resectable pa…
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Results: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for XB2001 in combination with ONIVYDE and 5-FU/LV (with or without folinic acid) in advanced pancreatic cancer have…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]
Phase 2 trial evaluating high-dose ascorbate in pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of ascorbic acid with NAB-paclitaxel protein-bound, cisplatin, and gemcitabine in pancreatic cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-07-13Clinical Trial Results: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 trial results for TC-510 in advanced mesothelin-expressing cancers were terminated with posted results.
-
EMA guidance · 2026-07-07EMA fast tracks review of a medicine for metastatic pancreatic cancer
EMA has started a phased review to accelerate assessment of a medicine with potential to treat metastatic pancreatic cancer, addressing a hi…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating antroquinonol in combination with standard of care in first-line metastatic pancreatic cancer; study completed wi…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]
Phase 2 trial assessing standard-of-care chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic can…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
Phase 2 trial results of a precision medicine approach (SMMART-ACT) in patients with advanced sarcoma, breast, ovarian, pancreatic, or prost…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 trial of daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active-not-recruiting, indicat…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
Phase 3 study of Daraxonrasib (RMC-6236) in previously treated metastatic pancreatic ductal adenocarcinoma is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Natural Killer Cells and Bortezomib to Treat Cancer [Phase 1]
This Phase 1 clinical trial update reports on the combination of natural killer cells and bortezomib for several cancers, and the study has …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigates peripheral blood lymphocytes engineered with a murine T-cell receptor targeting the G12V mutation in…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer [Phase 1]
A Phase 1 clinical trial evaluating a Personalized Peptide Vaccine for advanced colorectal cancer and pancreatic cancer is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Metarrestin (ML-246) in subjects with metastatic solid tumors; the study is currently recruiting across mu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) [Phase 1]
A Phase 1 trial evaluating gemcitabine with or without pitavastatin as the primary therapy for unresectable pancreatic adenocarcinoma; curre…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating the combination of gemcitabine, capecitabine, and erlotinib in patients with advanced pancreatic cancer has been …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation [Phase 2]
ClinicalTrials.gov update describes a Phase II randomized study (APOLLO) comparing olaparib versus placebo after curative-intent therapy in …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating the anti-CEACAM5 antibody-drug conjugate M9140 in adults with advanced solid tum…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy [NA]
This clinical trial compares a superior mesenteric artery-first approach versus the standard approach during pancreaticoduodenectomy for pan…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial evaluating the combination of gemcitabine, erlotinib, and nab-paclitaxel in basal-like pancreatic …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pancreatic Cancer Screening for At-risk Individuals
A clinical trial update indicating recruitment for pancreatic cancer screening in at-risk individuals is currently ongoing.